Journal
NATURE REVIEWS NEPHROLOGY
Volume 17, Issue 9, Pages 573-574Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41581-021-00449-9
Keywords
-
Categories
Ask authors/readers for more resources
New data from the ILLUMINATE-A trial demonstrate the safety and efficacy of lumasiran in patients with primary hyperoxaluria type 1. Further studies are needed to investigate the potential long-term benefits of this promising therapy.
New data from the ILLUMINATE-A trial of lumasiran demonstrate the safety and efficacy of this RNA interference therapeutic in patients with primary hyperoxaluria type 1. Further studies are required to investigate the potential long-term benefits of this promising therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
